Skip to main content

JADPRO Live 2024 Main banner

Icon Legend

ICONS KEY

CE Credit Available

CE Credit Available

Pharmacology Credit Available

Pharmacology Credit Available

Poster Activities

Poster Activities

Surgical Oncology

Surgical Oncology

Browse by Title

Browse by Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

B
Beyond Platinum: Current Approaches to Advanced Bladder Cancer

Saneese K. Stephen, MPAS, PA-C – The University of Texas MD Anderson Cancer Center ### 2403657###Speaker###HAL GUMO APP Supervisor###The University of Texas MD Anderson Cancer Center###
Speaker: Saneese K. Stephen, MPAS, PA-C – The University of Texas MD Anderson Cancer Center
### @@@ Arlene O. Siefker-Radtke, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center ### 2407086###Speaker###Professor###The University of Texas MD Anderson Cancer Center###
Speaker: Arlene O. Siefker-Radtke, MD (she/her/hers) – The University of Texas MD Anderson Cancer Center
### she/her/hers
Braindate
Braindate
Breakfast Activity/Non-CE Accredited Satellite Symposium: A Treatment Option for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
Merck
Seating is available on a first-come, first-served basis.
Breakfast Activity/Non-CE Accredited Satellite Symposium: A Treatment Option for Patients With Primary Advanced or Recurrent Endometrial Cancer
GSK
Breakfast Activity/Non-CE Accredited Satellite Symposium: An Outpatient Treatment Option for Patients with 3L+ Follicular Lymphoma, A Fixed-Duration Treatment Option for 3L+ Diffuse Large B-Cell Lymphoma
Genentech
Seating is available on a first-come, first-served basis.
Breakfast Activity/Non-CE Accredited Satellite Symposium: Adverse event management and patient adherence in gastric/GEJ cancer treatment: The vital role of advanced practitioners in supporting treatment with Claudin18.2 targeting therapy with emphasis on zolbetuximab
Astellas Pharma Inc
Breakfast Activity/Non-CE Accredited Satellite Symposium: CAR T Cell Therapy for 2L Large B-Cell Lymphoma (LBCL) and 3L Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Bristol Myers Squibb
Breakfast Activity/Non-CE Accredited Satellite Symposium: CARVYKTI® Product Summary for Patient Care Teams
Johnson & Johnson
Breakfast Activity/Non-CE Accredited Satellite Symposium: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
Pfizer, Inc.
Breakfast Activity/Non-CE Accredited Satellite Symposium: Treatment Option for Patients with Unresectable or Metastatic Melanoma
Bristol Myers Squibb
Breakfast Activity/Non-CE Accredited Satellite Symposium: Treatment Options for Patients with Metastatic Non-Small Cell Lung Cancer
Bristol Myers Squibb
Seating is available on a first-come, first-served basis.
Breakfast Activity/Non-CE Accredited Satellite Symposium: Understanding AYVAKIT for Indolent Systemic Mastocytosis (ISM)
Blueprint Medicines
Seating is available on a first-come, first-served basis.
Breakfast Activity/Non-CE Accredited Satellite Symposium: A Nurse's Guide to EGFR TKI Adverse Reaction Management
AstraZeneca